Anesthetic management in a pregnant woman with type 1 Gaucher disease

被引:3
|
作者
Pinto, J. [1 ]
Segura, E. [1 ]
Ribeiro, S. [1 ]
Amaral, R. [1 ]
机构
[1] Hosp Sao Teotonio Viseu, Viseu, Portugal
来源
关键词
Gaucher disease; Thrombocytopenia; Obstetrics; Epidural anesthesia; Cesarean section;
D O I
10.1016/S0034-9356(10)70212-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Gaucher disease is a genetic disorder in which the enzyme activity of lysosomal acid beta-glucocerebrosidase is impaired, causing excessive lysosomal storage of glucocerebrosidase in monocytes and macrophages. Coagulation and multiorgan disorders can develop during pregnancy in women with this disorder, affecting anesthetic management. We report the case of a woman with type 1 Gaucher disease who was scheduled for cesarean section. The blood workup showed evidence of hepatosplenomegaly and thrombocytopenia, osteopenia, and gastroesophageal reflux. Epidural anesthesia-analgesia was provided. Surgical conditions and analgesia were both satisfactory and no complications developed after withdrawal of the epidural catheter. We conclude that the management of anesthesia for pregnant women with Gaucher disease will depend on the degree of systemic involvement. Regional anesthesia has been used in many such patients, but there is insufficient literature on which to base guidelines or protocols.
引用
收藏
页码:243 / 244
页数:2
相关论文
共 50 条
  • [31] The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
    Cherin, P.
    Rose, C.
    de Roux-Serratrice, C.
    Tardy, D.
    Dobbelaere, D.
    Grosbois, B.
    Hachulla, E.
    Jaussaud, R.
    Javier, R. -M.
    Noel, E.
    Clerson, P.
    Hartmann, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) : 331 - 338
  • [32] Eliglustat: A Review in Gaucher Disease Type 1
    Scott, Lesley J.
    DRUGS, 2015, 75 (14) : 1669 - 1678
  • [33] GLYCOSYLATED FERRITIN IN TYPE 1 GAUCHER DISEASE
    Stirnemann, J.
    Heraoui, D.
    Boutenn, A.
    Fain, O.
    Fantin, B.
    Belmatoug, N.
    CLINICAL THERAPEUTICS, 2009, 31 : S208 - S209
  • [34] Jaws Features in Type 1 Gaucher Disease
    Zeevi, Itai
    Anavi, Yakir
    Kaplan, Ilana
    Zadik, Yehuda
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 71 (04) : 694 - 701
  • [35] Hyperferritinemia and diagnosis of type 1 Gaucher disease
    Marchi, Giacomo
    Nascimbeni, Fabio
    Motta, Irene
    Busti, Fabiana
    Carubbi, Francesca
    Cappellini, Maria Domenica
    Pietrangelo, Antonello
    Corradini, Elena
    Piperno, Alberto
    Girelli, Domenico
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (05) : 570 - 576
  • [36] Pregnant woman with neurological concomitant disease. Implications for the peripartal Management - Part 1
    Reif, Axel
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2008, 43 (04): : 254 - 254
  • [37] Parkinsonism in type 1 Gaucher's disease
    Spitz, M
    Rozenberg, R
    Silveira, PAA
    Barbosa, ER
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (05): : 709 - 710
  • [38] A therapeutic model for type 1 Gaucher disease
    Enquist, I. Berglin
    Nilsson, E.
    Ooka, A.
    Mansson, J. E.
    Olsson, K.
    Ehinger, M.
    Richter, J.
    Karlsson, S.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 49 - 49
  • [39] Life expectancy in Gaucher disease type 1
    Weinreb, Neal J.
    Deegan, Patrick
    Kacena, Katherine A.
    Mistry, Pramod
    Pastores, Gregory M.
    Velentgas, Priscilla
    vom Dahl, Stephan
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (12) : 896 - 900
  • [40] Type 1 nonneuronopathic Gaucher disease in children
    Kaplan, Paige
    CLINICAL THERAPEUTICS, 2007, 29 : S101 - S102